What investor type does Amgen fit best in FoxScore?

Amgen fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.

How meaningful is the available history for Amgen?

Amgen currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for Amgen

AMGN · As of: 02/17/2026

Basic information

Type: Stock

Region: US

Sector: Health Care

TER: –

History

Available history:15.0 years

Last tradingday:02/17/2026

Description & usage

Amgen is a biotechnology company developing biologics and medicines across areas such as oncology, inflammation, and rare diseases. Revenue comes from product sales as well as licensing and collaboration income. Customers include healthcare systems and patients worldwide, with a strong US market presence.

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

Amgen (AMGN) currently has a total score of 65 points, placing it in the strong range. The score is made up of Performance (57), Stability (73) and Trend (75).

Performance scores 57 points (neutral). Key strength: 1Y return at 26.0 %. Weaker metric: 10Y return at 161.6 %. This points to a sharper upswing more recently.

Stability scores 73 points (strong). Best-ranked metric: max drawdown (10Y) at -26.7 %. Main drag: volatility (365d, annualized) at 28.3 %. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 75 points (strong). Key strength: Price is about 15.4 % above SMA100. Main drag: 12M momentum at 11.1 %.

Overall, the score is shaped most by Trend; Performance trails and dampens the total. On a metric level, max drawdown (10Y) stands out, while volatility (365d, annualized) is the main weak spot.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

strong

Scores

Metrics

FAQ

What investor type does Amgen fit best in FoxScore?: Amgen fits a trend/momentum-oriented investor type in FoxScore: trend is clearly the strongest sub-score. This can be useful if you follow trends — but pay close attention to stability (drawdowns/volatility) because trend signals can flip quickly.
How meaningful is the available history for Amgen?: Amgen currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.